source
- Merck's China-sourced ADC shows survival benefit in Phase 3 endometrial cancer trialMerck & Co., in partnership with Chinese biotech Kelun-Biotech, reported that its experimental antibody-drug conjugate sacituzumab tirumotecan (Sac-TMT) met its primary endpoint in a global Phase 3…
- Trump administration cuts childhood vaccine schedule, citing personal autonomyThe opinion argues that the concept of patient autonomy does not apply to childhood vaccination because infants cannot refuse shots; the decision rests with parents. In January, the Department of…